Identification of Plasma Inflammatory Markers of Adolescent Depression Using the Olink Proteomics Platform

References

• Disease GBD, Injury I, Prevalence C. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet. 2017;390(10100):1211–1259.
   PubMed Web of Science ®Google Scholar
• Zhou X, Teng T, Zhang Y, et al. Comparative efficacy and acceptability of antidepressants, psychotherapies, and their combination for acute treatment of children and adolescents with depressive disorder: a systematic review and network meta-analysis. Lancet Psychiatry. 2020;7(7):581–601. doi:10.1016/S2215-0366(20)30137-1
   PubMed Web of Science ®Google Scholar
• Mokdad AH, Forouzanfar MH, Daoud F, et al. Global burden of diseases, injuries, and risk factors for young people’s health during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2016;387(10036):2383–2401. doi:10.1016/S0140-6736(16)00648-6
   PubMed Web of Science ®Google Scholar
• Cipriani A, Zhou X, Del Giovane C, et al. Comparative efficacy and tolerability of antidepressants for major depressive disorder in children and adolescents: a network meta-analysis. Lancet. 2016;388(10047):881–890. doi:10.1016/S0140-6736(16)30385-3
   PubMed Web of Science ®Google Scholar
• Teng T, Zhang Z, Yin B, et al. Effect of antidepressants on functioning and quality of life outcomes in children and adolescents with major depressive disorder: a systematic review and meta-analysis. Transl Psychiatry. 2022;12(1):183. doi:10.1038/s41398-022-01951-9
   PubMed Web of Science ®Google Scholar
• Leonard BE. Inflammation and depression: a causal or coincidental link to the pathophysiology? Acta Neuropsychiatr. 2018;30(1):1–16. doi:10.1017/neu.2016.69
   PubMed Web of Science ®Google Scholar
• Dowlati Y, Herrmann N, Swardfager W, et al. A meta-analysis of cytokines in major depression. Biol Psychiatry. 2010;67(5):446–457. doi:10.1016/j.biopsych.2009.09.033
   PubMed Web of Science ®Google Scholar
• Colasanto M, Madigan S, Korczak DJ. Depression and inflammation among children and adolescents: a meta-analysis. J Affect Disord. 2020;277:940–948. doi:10.1016/j.jad.2020.09.025
   PubMed Web of Science ®Google Scholar
• Wichers MC, Koek GH, Robaeys G, et al. Early increase in vegetative symptoms predicts IFN-alpha-induced cognitive-depressive changes. Psychol Med. 2005;35(3):433–441. doi:10.1017/S0033291704003526
   PubMed Web of Science ®Google Scholar
• Rice F, Riglin L, Lomax T, et al. Adolescent and adult differences in major depression symptom profiles. J Affect Disord. 2019;243:175–181. doi:10.1016/j.jad.2018.09.015
   PubMed Web of Science ®Google Scholar
• Lutgendorf SK, Weinrib AZ, Penedo F, et al. Interleukin-6, cortisol, and depressive symptoms in ovarian cancer patients. J Clin Oncol. 2008;26(29):4820–4827. doi:10.1200/JCO.2007.14.1978
   PubMed Web of Science ®Google Scholar
• Inagaki M, Akechi T, Okuyama T, et al. Associations of interleukin-6 with vegetative but not affective depressive symptoms in terminally ill cancer patients. Support Care Cancer. 2013;21(8):2097–2106. doi:10.1007/s00520-013-1767-x
   PubMed Web of Science ®Google Scholar
• Geyer PE, Holdt LM, Teupser D, et al. Revisiting biomarker discovery by plasma proteomics. Mol Syst Biol. 2017;13(9):942. doi:10.15252/msb.20156297
   PubMed Web of Science ®Google Scholar
• Tian T, Yang Y, Xu B, et al. Pigment epithelium-derived factor alleviates depressive-like behaviors in mice by modulating adult hippocampal synaptic growth and Wnt pathway. Prog Neuropsychopharmacol Biol Psychiatry. 2020;98:109792. doi:10.1016/j.pnpbp.2019.109792
   PubMed Web of Science ®Google Scholar
• Yang Y, Chen J, Liu C, et al. The Extrinsic Coagulation Pathway: a Biomarker for Suicidal Behavior in Major Depressive Disorder. Sci Rep. 2016;6(1):32882. doi:10.1038/srep32882
   PubMedGoogle Scholar
• Petrera A, von Toerne C, Behler J, et al. Multiplatform Approach for Plasma Proteomics: complementarity of Olink Proximity Extension Assay Technology to Mass Spectrometry-Based Protein Profiling. J Proteome Res. 2021;20(1):751–762. doi:10.1021/acs.jproteome.0c00641
   PubMed Web of Science ®Google Scholar
• Isgren A, Göteson A, Holmén-Larsson J, et al. Cerebrospinal fluid proteomic study of two bipolar disorder cohorts. Mol Psychiatry. 2022;27(11):4568–4574. doi:10.1038/s41380-022-01724-2
   PubMed Web of Science ®Google Scholar
• Carlyle BC, Kitchen RR, Mattingly Z, et al. Technical Performance Evaluation of Olink Proximity Extension Assay for Blood-Based Biomarker Discovery in Longitudinal Studies of Alzheimer’s Disease. Front Neurol. 2022;13:889647. doi:10.3389/fneur.2022.889647
   PubMed Web of Science ®Google Scholar
• Hijazi Z, Wallentin L, Lindbäck J, et al. Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial Fibrillation. J Am Heart Assoc. 2020;9(24):e018984. doi:10.1161/JAHA.120.018984
   PubMed Web of Science ®Google Scholar
• Pu J, Yu Y, Liu Y, et al. MENDA: a comprehensive curated resource of metabolic characterization in depression. Brief Bioinform. 2020;21(4):1455–1464. doi:10.1093/bib/bbz055
   PubMed Web of Science ®Google Scholar
• Zhang L, Liu C, Li Y, et al. Plasma biomarker panel for major depressive disorder by quantitative proteomics using ensemble learning algorithm: a preliminary study. Psychiatry Res. 2023;323:115185. doi:10.1016/j.psychres.2023.115185
   PubMed Web of Science ®Google Scholar
• Liang J-Q, Liao H-R, Xu C-X, et al. Serum Exosome-Derived miR-139-5p as a Potential Biomarker for Major Depressive Disorder. Neuropsychiatr Dis Treat. 2020;16:2689–2693. doi:10.2147/NDT.S277392
   PubMed Web of Science ®Google Scholar
• Wei Z-X, Xie G-J, Mao X, et al. Exosomes from patients with major depression cause depressive-like behaviors in mice with involvement of miR-139-5p-regulated neurogenesis. Neuropsychopharmacology. 2020;45(6):1050–1058. doi:10.1038/s41386-020-0622-2
   PubMed Web of Science ®Google Scholar
• Liu YF, Liang -J-J, Ng TK, et al. CXCL5/CXCR2 modulates inflammation-mediated neural repair after optic nerve injury. Exp Neurol. 2021;341:113711. doi:10.1016/j.expneurol.2021.113711
   PubMed Web of Science ®Google Scholar
• Roca H, Jones JD, Purica MC, et al. Apoptosis-induced CXCL5 accelerates inflammation and growth of prostate tumor metastases in bone. J Clin Invest. 2018;128(1):248–266. doi:10.1172/JCI92466
   PubMed Web of Science ®Google Scholar
• Nouailles G, Dorhoi A, Koch M, et al. CXCL5-secreting pulmonary epithelial cells drive destructive neutrophilic inflammation in tuberculosis. J Clin Invest. 2014;124(3):1268–1282. doi:10.1172/JCI72030
   PubMed Web of Science ®Google Scholar
• Pickens SR, Chamberlain ND, Volin MV, et al. Anti-CXCL5 therapy ameliorates IL-17-induced arthritis by decreasing joint vascularization. Angiogenesis. 2011;14(4):443–455. doi:10.1007/s10456-011-9227-z
   PubMed Web of Science ®Google Scholar
• Wu H, Wang J, Teng T, et al. Biomarkers of intestinal permeability and blood-brain barrier permeability in adolescents with major depressive disorder. J Affect Disord. 2023;323:659–666. doi:10.1016/j.jad.2022.11.058
   PubMed Web of Science ®Google Scholar
• Rudzki L, Maes M. The Microbiota-Gut-Immune-Glia (MGIG) Axis in Major Depression. Mol Neurobiol. 2020;57(10):4269–4295. doi:10.1007/s12035-020-01961-y
   PubMed Web of Science ®Google Scholar
• Koper OM, Kamińska J, Sawicki K, et al. CXCL9, CXCL10, CXCL11, and their receptor (CXCR3) in neuroinflammation and neurodegeneration. Adv Clin Exp Med. 2018;27(6):849–856. doi:10.17219/acem/68846
   PubMed Web of Science ®Google Scholar
• Szczucinski A, Kalinowska A, Losy J. CXCL11 (Interferon-inducible T-cell alpha chemoattractant) and interleukin-18 in relapsing-remitting multiple sclerosis patients treated with methylprednisolone. Eur Neurol. 2007;58(4):228–232. doi:10.1159/000107945
   PubMed Web of Science ®Google Scholar
• Mousessian AS, da Silva CP, Oba-Shinjo SM, et al. CXCR7, CXCR4, and Their Ligand Expression Profile in Traumatic Brain Injury. World Neurosurg. 2021;147:e16–e24. doi:10.1016/j.wneu.2020.11.022
   PubMed Web of Science ®Google Scholar
• Leighton SP, Nerurkar L, Krishnadas R, et al. Chemokines in depression in health and in inflammatory illness: a systematic review and meta-analysis. Mol Psychiatry. 2018;23(1):48–58. doi:10.1038/mp.2017.205
   PubMed Web of Science ®Google Scholar
• Perna L, Trares K, Perneczky R, et al. Risk of Late-Onset Depression and Cognitive Decline: results From Inflammatory Proteome Analyses in a Prospective Population-Based Cohort Study. Am J Geriatr Psychiatry. 2022;30(6):689–700. doi:10.1016/j.jagp.2021.12.001
   PubMed Web of Science ®Google Scholar
• Poletti S, Mazza MG, Calesella F, et al. Circulating inflammatory markers impact cognitive functions in bipolar depression. J Psychiatr Res. 2021;140:110–116. doi:10.1016/j.jpsychires.2021.05.071
   PubMed Web of Science ®Google Scholar
• Poletti S, Vai B, Mazza MG, et al. A peripheral inflammatory signature discriminates bipolar from unipolar depression: a machine learning approach. Prog Neuropsychopharmacol Biol Psychiatry. 2021;105:110136. doi:10.1016/j.pnpbp.2020.110136
   PubMed Web of Science ®Google Scholar
• Tawdy MH, Abd El Nasser MM, Abd El Shafy SS, et al. Role of serum TRAIL level and TRAIL apoptosis gene expression in multiple sclerosis and relation to brain atrophy. J Clin Neurosci. 2014;21(9):1606–1611. doi:10.1016/j.jocn.2013.11.056
   PubMed Web of Science ®Google Scholar
• Qin L, Zou J, Barnett A, et al. TRAIL Mediates Neuronal Death in AUD: a Link between Neuroinflammation and Neurodegeneration. Int J Mol Sci. 2021;22(5):2547. doi:10.3390/ijms22052547
   PubMed Web of Science ®Google Scholar
• Larsson A, Carlsson L, Gordh T, et al. The effects of age and gender on plasma levels of 63 cytokines. J Immunol Methods. 2015;425:58–61. doi:10.1016/j.jim.2015.06.009
   PubMed Web of Science ®Google Scholar
• Leandersson P, Åkesson A, Hedenfalk I, et al. A multiplex biomarker assay improves the diagnostic performance of HE4 and CA125 in ovarian tumor patients. PLoS One. 2020;15(10):e0240418. doi:10.1371/journal.pone.0240418
   PubMed Web of Science ®Google Scholar
• Ahn D, Prince A. Participation of the IL-10RB Related Cytokines, IL-22 and IFN-lambda in Defense of the Airway Mucosal Barrier. Front Cell Infect Microbiol. 2020;10:300. doi:10.3389/fcimb.2020.00300
   PubMed Web of Science ®Google Scholar
• Frede N, Glocker E-O, Wanders J, et al. Evidence for non-neutralizing autoantibodies against IL-10 signalling components in patients with inflammatory bowel disease. BMC Immunol. 2014;15(1):10. doi:10.1186/1471-2172-15-10
   PubMedGoogle Scholar
• Ohlsson L, Gustafsson A, Lavant E, et al. Leaky gut biomarkers in depression and suicidal behavior. Acta Psychiatr Scand. 2019;139(2):185–193. doi:10.1111/acps.12978
   PubMed Web of Science ®Google Scholar
• Stevens BR, Goel R, Seungbum K, et al. Increased human intestinal barrier permeability plasma biomarkers zonulin and FABP2 correlated with plasma LPS and altered gut microbiome in anxiety or depression. Gut. 2018;67(8):1555–1557. doi:10.1136/gutjnl-2017-314759
   PubMed Web of Science ®Google Scholar